Abstract :
Tooth loss can have an impact on one's quality of life. One of the most common problems is alveolar bone loss induced by periodontal disease or surgery (trauma). A bone transplant is a material that may be used to repair bone loss. Chitosan has been demonstrated in studies to hasten wound healing. The pericardium membrane is an appropriate component for augmentation of the alveolar ridge deficiency. Barrier membranes have been designed and tested to keep epithelial and connective tissue cells from penetrating the void. To determine and explain the influence of the pericardium membrane on the adsorption rate of blood type O in chitosan powder sizes 150-355 μm. 14 chitosan samples measuring 150-355 m were separated into two groups: the control group, which included 7 samples of chitosan with pericardium membrane and 7 samples of chitosan without pericardium membrane, and the treatment group, which included 7 samples of chitosan without pericardium membrane. Immerse it in 75 mL of blood. For 10 minutes, measurements of group O blood adsorption rate were taken in each group. The results were statistically examined using the Mann-Whitney test (p<0.05). There was a statistically significant difference between the control and treatment groups. When the adsorption rate of blood type O in chitosan with and without membrane pericardium is compared, there are significant different. There is a difference in the rate of blood adsorption on 150-355 μm of chitosan with the pericardium membrane.
